Journal of Athletic EnhancementISSN: 2324-9080

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Non-Therapeutic Insulin Use in Resistance-Trained Men

Non-Therapeutic Insulin Use in Resistance-Trained Men

Limited evidence exists detailing the ergogenic use of nontherapeutic insulin. This study sought to further clarify the nontherapeutic insulin use in resistance-trained men using the validated, 37-item, Strength Training Ergogenic Survey (STES). Self-selected subjects completed the Internet-based STES. The final sample included 199 male, non-type I diabetic, respondents. Of all respondents, 27.1% used non-therapeutic insulin, all but one of whom also used anabolic-androgenic steroids (98.1%). Those using non-therapeutic insulin were older, bigger, had greater annual incomes, and trained longer, when compared to non-users. Users were more likely European as well as being participants in either bodybuilding or powerlifting. Most believed some of their competitor’s used non-therapeutic insulin. Over four-in-five (81.5%) of non-therapeutic insulin users administered the drug after training and almost all (94.4%) administered it in a cyclic fashion. Reasons cited for non-therapeutic insulin use included: improve physique (84.2%), improve muscle mass (73.3%, and decrease fat (67.9%). Polypharmacy was the norm among non-therapeutic insulin users, as almost all (91.0%) respondents also abused anabolic-androgenic steroids or other drugs. The current study substantiates nontherapeutic insulin use by this sample of resistance trained males, with unknown, but potentially negative, health consequences. Non-therapeutic insulin use is a relevant issue for strength and conditioning specialists, fitness professionals, and healthcare practitioners. The non-therapeutic use of insulin may be increasing, necessitating a better understanding by all concerned, as well as further study by researchers.

Special Features

Full Text


Track Your Manuscript

Media Partners